NCT06599515 SetUp Study for HugoTM RAS Inguinal Hernia Repair
| NCT ID | NCT06599515 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Algemeen Ziekenhuis Maria Middelares |
| Condition | Inguinal Hernia |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-09-15 |
| Primary Completion | 2025-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-09-15 with a primary completion date of 2025-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational cohort study is to evaluate the evolution of the operative time in performing robotic assisted laparoscopic inguinal hernia repair (rTAPP) during the learning curve of the first 50 patients using the HugoTM Ras (Medtronic) robotic system using the setup guide. Researchers will compare to the operative time for rTAPP of 50 patients by the same surgeon in another hospital using the daVinci Xi (Intuitive Surgical) robotic system.
Eligibility Criteria
Inclusion Criteria: All patients planned for a minimal invasive (robotic assisted laparoscopic) inguinal hernia repair during the study period will be invited to take part in the study. Both unilateral and bilateral hernias will be included. Exclusion Criteria: * Recurrent hernias after previous preperitoneal mesh placement. * Inguinal hernias after abdominal prostatectomy. * Pregnancy. * Emergency surgery. * Age below 18 years. * Absence of informed consent.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06599515 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Inguinal Hernia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06599515 currently recruiting?
Yes, NCT06599515 is actively recruiting participants. Contact the research team at Filip.Muysoms@mijnziekenhuis.be for enrollment information.
Where is the NCT06599515 trial being conducted?
This trial is being conducted at Deinze, Belgium, Ghent, Belgium.
Who is sponsoring the NCT06599515 clinical trial?
NCT06599515 is sponsored by Algemeen Ziekenhuis Maria Middelares. The trial plans to enroll 100 participants.